ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $245,000 | +45.0% | 235,879 | +3.6% | 0.00% | – |
| Q4 2018 | $169,000 | -66.9% | 227,637 | -5.6% | 0.00% | – |
| Q3 2018 | $510,000 | -7.3% | 241,203 | +1.3% | 0.00% | – |
| Q2 2018 | $550,000 | -21.7% | 238,139 | +7.8% | 0.00% | – |
| Q1 2018 | $702,000 | -23.6% | 221,006 | -1.4% | 0.00% | – |
| Q4 2017 | $919,000 | -74.3% | 224,157 | -71.7% | 0.00% | – |
| Q3 2017 | $3,581,000 | +37.6% | 792,338 | +1.4% | 0.00% | – |
| Q2 2017 | $2,603,000 | -83.3% | 781,773 | -53.9% | 0.00% | -100.0% |
| Q1 2017 | $15,604,000 | +119930.8% | 1,694,365 | +97840.2% | 0.00% | – |
| Q4 2016 | $13,000 | -38.1% | 1,730 | -8.7% | 0.00% | – |
| Q3 2016 | $21,000 | +16.7% | 1,895 | +28.4% | 0.00% | – |
| Q2 2016 | $18,000 | +50.0% | 1,476 | +19.9% | 0.00% | – |
| Q1 2016 | $12,000 | -7.7% | 1,231 | +114.1% | 0.00% | – |
| Q4 2015 | $13,000 | +160.0% | 575 | +94.9% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 295 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | -12.5% | 295 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | +33.3% | 295 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 295 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 295 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | – | 295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|